Association of CD38 Antigen Expression with Other Prognostic Parameters in Early Stages of Chronic Lymphocytic Leukemia

References

• Binet J. L., Auquier A., Dighiero G., et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981; 48: 198–206
   PubMed Web of Science ®Google Scholar
• Hallek M., Kuhn-Hallek I., Emmerich B. Prognostic factors in chronic lymphocytic leukemia. Leukemia 1997; 11((Suppl. 2))4–13
   Google Scholar
• Juliusson G., Merup M. Cytogenetics in chronic lymphocytic leukemia. Semin. Oncol. 1998; 25: 19–26
   PubMed Web of Science ®Google Scholar
• Lechner K., Jaeger U., Geissler K., Greinix H., Kahls P. Advances in the treatment of chronic lymphocytic leukemia (CLL). Wen Kiln Wochenschr 1998; 110/20: 701–708
   Web of Science ®Google Scholar
• Molica S. Progression and survival studies in early chronic lymphocytic leukemia. Blood 1991; 78: 895–899
   PubMed Web of Science ®Google Scholar
• Rai K. R., Sawitsky A., Cronkite E. P., Chanana A. D., Levy R. N., Pasternack B. S. Clinical staging of chronic lymphocytic leukemia. Blood 1975; 46: 219–234
   PubMed Web of Science ®Google Scholar
• Rozman C., Montserrat E. Chronic lymphocytic leukemia. N. Engl. J. Med. 1995; 333: 1052–1057
   PubMed Web of Science ®Google Scholar
• Dighiero G., Maloum K., Desablens B., et al. Chlorambucil in indolent chronic lymphocytic leukemia. N. Engl. J. Med. 1998; 338: 1506–1514
   PubMed Web of Science ®Google Scholar
• Keating M. J., O'Brian S., et al. Long-term follow up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agent. Blood 1991; 81: 2878–2884
   Web of Science ®Google Scholar
• Michallet M., Thiebaut A., Dreger P., Remes K., Milpied N., Santini G., Hamon M., Bjorkstrand B., Kimby E., Beihabri A., Tanguy ML., Apperley J. F. Peripheral blood stem cell (PBSC) mobilization and transplantation after fludarabine therapy in chronic lymphocytic leukemia (CLL): a report of the European Blood and Marrow Transplantation (EBMT) CLL subcommittee on behalf of the EBMT Chronic Leukemias Working Party (CLWP). Br. J. Haematol. 2000; 108(3)595–601
   PubMed Web of Science ®Google Scholar
• Rai K. R., Peterson B. L., Appelbaum F. R., Kolitz J., Elias L., Shepherd L., Hines J., Threat G. A., Larson R. A., Cheson B. D., Schiffer C. A. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia. N. Engl. J. Med. 2000; 343(24)1750–1757
   PubMed Web of Science ®Google Scholar
• Zwiebel J. A., Cheson B. D. Chronic lymphocytic leukemia: staging and prognostic factors. Semin. Oncol. 1998; 25: 42–59
   PubMed Web of Science ®Google Scholar
• Molica S., Levato D., Cascavilla N., Levato L., Musto P. Clinico-prognostic implications of simultaneous increased serum levels of soluble CD23 and beta 2-microglobulin in B-cell chronic lymphocytic leukemia. Eur. J. Haematol. 1999; 62(2)117–122
   PubMed Web of Science ®Google Scholar
• Sarfati M., Chevret S., Chastang C., Biron G., Stryckmans P., Delespesse G., Binet I. L., Merle-Beral H., Bron D. Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia. Blood 1996; 88: 4259–4264
   PubMed Web of Science ®Google Scholar
• Leotard S., Chastang C., Travade P., Jaudon M. C., Tournilhac O., Baudet S., Merle-Beral H. Prognostic relevance of a scoring system based on clinical and biological parameters in early chronic lymphocytic leukemia. Hematol. J. 2000; 1: 301–306
   PubMedGoogle Scholar
• Hallek M., Langenmayer I., Nerl C., Knauf W., Dietzfelbinger H., Adorf D., Ostwald M., Busch R., Kuhn-Hallek I., Thiel E., Emmerich B. Elevated serum thymidine kinase level identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia. Blood 1999; 3: 1732–1737
   Google Scholar
• Döhner H., Stilgenbauer S., Benner A., Leupolt E., Krober A., Bulhinger L., Döhner K., Bentz M., Lichter P. Genomic aberrations and survival in chronic lymphocytic leukemia. N. Engl. J. Med. 2000; 343(26)1910–1916
   PubMed Web of Science ®Google Scholar
• Stilgenbauer S., Döhner K., Bentz M., Lichter P., Döhner H. Molekular cytogenetic analysis of B-cell chronic lymphocytic leukemia. Ann. Hematol. 1998; 76: (3–4), 101–110
   Web of Science ®Google Scholar
• Hamblin T. J., Davis Z., Gardiner A., Oscier D. G., Stevenson F. K. Unmutated Ig V H Genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999; 94: 1848–1854
   PubMed Web of Science ®Google Scholar
• Damle R. N., Wasil T., Fais F., Ghiotto F., Valetto A., Allen S. L., Buchbinder A., Budman D., Dittmar K., Kolitz J., Lichtman S. M., Schulman P., Vinciguerra V. P., Rai K. R., Ferrarini M., Chiorazzi N. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94: 1840–1847
   PubMed Web of Science ®Google Scholar
• Damle R. N., Fais F., Ghiotto F., Valetto A., Albesiano E., Wasil T., Batliwalla F. M., Allen S. L., Schulman P., Vinciguerra V. P., Rai K. R., Gregersen P. K., Ferrarini M., Chiorazzi N. Chronic lymphocytic leukemia: a proliferation of B cells at two distinct stages of differentiation. Curr. Top. Microbiol. Immunol. 2000; 252: 285–292
   PubMed Web of Science ®Google Scholar
• Widhopf G. F., Marathe CM, Rassenti L. Z., Byrd J. C., Flinn I. W., Gribben J. G., Kipps T. J. Lack of correlation between immunoglobulin somatic mutation and expression of CD38 in chronic lymphocytic leukemia. Proceedings of the 42nd Annual Meeting of the American Society of Hematology, San Francisco, November, 162000. 96: 367a
   Google Scholar
• Cheson B. D., Benelt J. M., Grever M., et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996; 87: 4990–4997
   PubMed Web of Science ®Google Scholar
• Reinisch W., Wiliheim M., Hilgarth M., Gasche C., Mader R., Szepfalusi S., Steger G., Berger R., Lechner K., Boltz-Nitulescu G., Schwarzmeier J. D. Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemia. J. Clin. Oncol. 1994; 12(10)2146–2152
   PubMed Web of Science ®Google Scholar
• Hamblin T. J., Orchard J. A., Gardiner A., Oscier D. G., Davis Z., Stevenson F. K. Immunglobulin V genes and CD38 expression in CLL. Blood 2000; 95: 2455–2456
   PubMed Web of Science ®Google Scholar
• Rosenquist R., Thunberg U., Johnson A., Roos G., Thorn I., Tobin G., Sallstrom J., Sundstrom C. CD38 Expression is a poor predictor for VH gene mutation status and prognosis in chronic lymphocytic leukemia. Proceedings of the 42nd Meeting of the American Society of Hematology, San Francisco, November, 162000. 96: 367a, Intr. by Simmonsson, B.
   Google Scholar